
Canopy Growth Corp
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- $1.31
- Today's High:
- $1.92
- Open Price:
- $1.5
- 52W Low:
- $0.711
- 52W High:
- $4.77
- Prev. Close:
- $1.69
- Volume:
- 194420823
Company Statistics
- Market Cap.:
- $410.54 million
- Book Value:
- 2.881
- Revenue TTM:
- $440.96 million
- Operating Margin TTM:
- -114.96%
- Gross Profit TTM:
- $-81938000
- Profit Margin:
- 0%
- Return on Assets TTM:
- -6.79%
- Return on Equity TTM:
- -112%
Company Profile
Canopy Growth Corp had its IPO on 2014-04-04 under the ticker symbol CGC.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Canopy Growth Corp has a staff strength of 3,151 employees.
Stock update
Shares of Canopy Growth Corp opened at $1.5 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $1.31 - $1.92, and closed at $1.34.
This is a -20.71% slip from the previous day's closing price.
A total volume of 194,420,823 shares were traded at the close of the day’s session.
In the last one week, shares of Canopy Growth Corp have increased by +143.64%.
Canopy Growth Corp's Key Ratios
Canopy Growth Corp has a market cap of $410.54 million, indicating a price to book ratio of 1.167 and a price to sales ratio of 2.6555.
In the last 12-months Canopy Growth Corp’s revenue was $440.96 million with a gross profit of $-81938000 and an EBITDA of $-412688992. The EBITDA ratio measures Canopy Growth Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Canopy Growth Corp’s operating margin was -114.96% while its return on assets stood at -6.79% with a return of equity of -112%.
In Q4, Canopy Growth Corp’s quarterly earnings growth was a positive 0% while revenue growth was a negative 28.2%.
Canopy Growth Corp’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-5.24 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Canopy Growth Corp’s profitability.
Canopy Growth Corp stock is trading at a EV to sales ratio of 3.425 and a EV to EBITDA ratio of -0.5888. Its price to sales ratio in the trailing 12-months stood at 2.6555.
Canopy Growth Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $3.02 billion
- Total Liabilities
- $678.74 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $2.20 million
- Dividend Payout Ratio
- 0%
Canopy Growth Corp ended 2023 with $3.02 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $3.02 billion while shareholder equity stood at $1.43 billion.
Canopy Growth Corp ended 2023 with $0 in deferred long-term liabilities, $678.74 million in other current liabilities, 7867310000.00 in common stock, $-8937603000.00 in retained earnings and $142.08 million in goodwill. Its cash balance stood at $598.13 million and cash and short-term investments were $789.25 million. The company’s total short-term debt was $455,483,000 while long-term debt stood at $750.12 million.
Canopy Growth Corp’s total current assets stands at $1.17 billion while long-term investments were $151.85 million and short-term investments were $191.12 million. Its net receivables were $104.64 million compared to accounts payable of $63.14 million and inventory worth $213.94 million.
In 2023, Canopy Growth Corp's operating cash flow was $0 while its capital expenditure stood at $2.20 million.
Comparatively, Canopy Growth Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $1.34
- 52-Week High
- $4.77
- 52-Week Low
- $0.711
- Analyst Target Price
- $1.52
Canopy Growth Corp stock is currently trading at $1.34 per share. It touched a 52-week high of $4.77 and a 52-week low of $4.77. Analysts tracking the stock have a 12-month average target price of $1.52.
Its 50-day moving average was $0.52 and 200-day moving average was $1.58 The short ratio stood at 5.4 indicating a short percent outstanding of 0%.
Around 3353.1% of the company’s stock are held by insiders while 1421.2% are held by institutions.
Frequently Asked Questions About Canopy Growth Corp
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company’s products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.